Molecular Insights Into -Linked Glycan Utilization by Gut Microbes
Overview
Affiliations
-linked glycosylation is a post-translational modification found mainly in eukaryotic cells, which covalently attaches oligosaccharides to secreted proteins in certain threonine or serine residues. Most of -glycans have -acetylgalactosamine (GalNAc) as a common core. Several glycoproteins, such as mucins (MUCs), immunoglobulins, and caseins are examples of -glycosylated structures. These glycans are further elongated with other monosaccharides and sulfate groups. Some of them could be found in dairy foods, while others are produced endogenously, in both cases interacting with the gut microbiota. Interestingly, certain gut microbes can access, release, and consume -linked glycans as a carbon source. Among these, , , and are prominent -linked glycan utilizers. Their consumption strategies include specialized -fucosidases and α-sialidases, in addition to endo---acetylgalactosaminidases that release galacto--biose (GNB) from peptides backbones. -linked glycan utilization by certain gut microbes represents an important niche that allows them to predominate and modulate host responses such as inflammation. Here, we focus on the distinct molecular mechanisms of consumption of -linked GalNAc glycans by prominent gut microbes, especially from mucin and casein glycomacropeptide (GMP), highlighting the potential of these structures as emerging prebiotics.
Discovery and Characterization of Unusual O-Linked Glycosylation of IgG4 Antibody Using LC-MS.
Janecki D, Kao-Scharf C, Hoffmann A Rapid Commun Mass Spectrom. 2024; 39(5):e9969.
PMID: 39663547 PMC: 11635057. DOI: 10.1002/rcm.9969.
de Ram C, van der Lugt B, Elzinga J, Geerlings S, Steegenga W, Belzer C J Agric Food Chem. 2024; 72(27):15345-15356.
PMID: 38932522 PMC: 11247495. DOI: 10.1021/acs.jafc.4c01401.
Uehara M, Inoue T, Hase S, Sasaki E, Toyoda A, Sakakibara Y mSystems. 2024; 9(5):e0140523.
PMID: 38557130 PMC: 11097647. DOI: 10.1128/msystems.01405-23.
Matsuzaki C, Takagi H, Saiga S, Kinoshita Y, Yamaguchi M, Higashimura Y Appl Environ Microbiol. 2024; 90(3):e0144523.
PMID: 38411084 PMC: 10952502. DOI: 10.1128/aem.01445-23.
Antivirals for Broader Coverage against Human Coronaviruses.
Outteridge M, Nunn C, Devine K, Patel B, McLean G Viruses. 2024; 16(1).
PMID: 38275966 PMC: 10820748. DOI: 10.3390/v16010156.